NASDAQ:XERS

Xeris Biopharma Holdings, Inc.

Stock

USD

Last Close

7.71

06/11 22:33

Market Cap

319.49M

Beta: -

Volume Today

1.82M

Avg: 1.25M

PE Ratio

−4.97

PFCF: −4.75

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	1.07M -	1.56M 44.74%	2.46M 58.42%	20.16M 717.65%	49.59M 146.04%	110.25M 122.32%	110.25M 0%	163.91M 48.68%
cost of revenue	8K -	4K 50%	42K 950%	9.33M 22,109.52%	13.32M 42.77%	22.63M 69.95%	22.63M 0%	39.49M 74.46%
gross profit	1.07M -	1.55M 45.45%	2.42M 56.12%	10.83M 346.84%	36.27M 235.01%	87.61M 141.55%	87.61M 0%	124.43M 42.02%
selling and marketing expenses
general and administrative expenses	4.06M -	8.02M 97.41%	21.11M 163.42%
selling general and administrative expenses	4.06M -	8.02M 97.41%	21.11M 163.42%	73.73M 249.23%	125.72M 70.51%	137.75M 9.57%	137.75M 0%	146.09M 6.06%
research and development expenses	10.24M -	20.17M 96.97%	40.65M 101.60%	20.92M 48.54%	25.16M 20.26%	20.97M 16.67%	20.97M 0%	22.34M 6.56%
other expenses	-5K -	-1K 80%		-280K -	550K 296.43%	10.84M 1,871.45%	-14.14M 230.44%
cost and expenses	14.31M -	28.18M 97.02%	61.81M 119.30%	103.70M 67.78%	164.75M 58.87%	192.19M 16.66%	192.19M 0%	207.92M 8.19%
operating expenses	14.30M -	28.18M 97.10%	61.77M 119.18%	94.37M 52.79%	151.43M 60.46%	169.55M 11.97%	169.55M 0%	168.44M 0.66%
interest expense	2K -	2K 0%	2.54M 127,150%	10.66M 318.86%	7.18M 32.65%	15.32M 113.44%	15.32M 0%	26.61M 73.63%
ebitda	-13.12M -	-26.33M 100.75%	-57.73M 119.27%	-80.58M 39.58%	-114.61M 42.22%	-71.10M 37.96%	-71.10M 0%	-30.85M 56.61%
operating income	-13.23M -	-26.63M 101.26%	-59.34M 122.85%	-83.55M 40.78%	-115.16M 37.84%	-81.94M 28.84%	-81.94M 0%	-44.01M 46.29%
depreciation and amortization	116K -	177K 52.59%	320K 80.79%	2.96M 826.56%	550K 81.45%	10.84M 1,871.45%	10.84M 0%	13.16M 21.37%
total other income expenses net	19K -	-47K 347.37%	196K 517.02%	-7.70M 4,030.61%	-7.57M 1.75%	-14.14M 86.87%	-14.14M 0%	-19.49M 37.83%
income before tax	-13.21M -	-26.55M 101.03%	-60.08M 126.26%	-91.25M 51.88%	-122.72M 34.49%	-96.08M 21.71%	-96.08M 0%	-63.50M 33.91%
income tax expense	-3K -	1K 133.33%	1.81M 180,800%	-110K 106.08%	-110K 0%	-1.42M 1,194.55%	-1.42M 0%	-1.25M 12.29%
net income	-13.21M -	-26.55M 101.03%	-60.08M 126.26%	-91.14M 51.70%	-122.72M 34.66%	-94.66M 22.87%	-94.66M 0%	-62.26M 34.23%
weighted average shs out	2.17M -	2.17M 0%	12.05M 455.22%	42.64M 254.00%	79.03M 85.32%	135.63M 71.62%	135.63M 0%	137.67M 1.51%
weighted average shs out dil	2.17M -	2.17M 0%	12.05M 455.22%	42.64M 254.00%	79.03M 85.32%	135.63M 71.62%	135.63M 0%	137.67M 1.51%
eps	-6.09 -	-12.24 100.99%	-4.99 59.23%	-2.14 57.11%	-1.55 27.57%	-0.70 54.84%	-0.70 0%	-0.45 35.71%
epsdiluted	-6.09 -	-12.24 100.99%	-4.99 59.23%	-2.14 57.11%	-1.55 27.57%	-0.70 54.84%	-0.70 0%	-0.45 35.71%

All numbers in USD (except ratios and percentages)